6,6′-Aryl trehalose analogs as potential Mincle ligands
Authors:
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 28 (14) , 115564
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
This publication has 50 references indexed in Scilit:
- The Mincle-Activating Adjuvant TDB Induces MyD88-Dependent Th1 and Th17 Responses through IL-1R SignalingPLOS ONE, 2013
- Probing the Mycobacterial Trehalome with Bioorthogonal ChemistryJournal of the American Chemical Society, 2012
- Long‐Chain Lipids Are Required for the Innate Immune Recognition of Trehalose Diesters by MacrophagesChemBioChem, 2011
- Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01Vaccine, 2011
- Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosisNature Chemical Biology, 2011
- Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-DibehenateThe Journal of Immunology, 2010
- Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin MincleJournal of Experimental Medicine, 2009
- Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activationJournal of Experimental Medicine, 2009
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological RequirementsPLOS ONE, 2008
- IL-23 and IL-17 in tuberculosisCytokine, 2008